Zhang Qian, Zhou Jing, Zhu Dongmei, Zhou Suming
Department of Geriatrics ICU, the First Affiliated Hospital with Nanjing Medical University, Nanjing, People's Republic of China.
Nutr Clin Pract. 2022 Apr;37(2):402-412. doi: 10.1002/ncp.10672. Epub 2021 Jun 8.
Our aim was to evaluate the effect of high protein to the target of 2.0 g/kg/d on diaphragm atrophy and clinical prognosis of patients receiving prolonged mechanical ventilation (MV).
This prospective, randomized, controlled, single-center study included 41 patients who were treated with ≥7 days' MV. The patients were randomly divided into a standard nutrition treatment (SNT) group and intensive nutrition treatment (INT) group, followed by evaluation of computer tomography-analyzed diaphragm volume, the level of butyrylcholinesterase (BChE) as a muscle mass indicator, and respiratory mechanics indices weekly to observe and compare the differences between the groups.
In the INT group, the actual protein (1.70 ± 0.21 vs 1.06 ± 0.21 g/kg/d, P < .001) and calorie intake (33.46 ± 2.78 vs 25.75 ± 4.81 kcal/kg/d, P < .001) were significantly different from those of the SNT group. Compared with the SNT group, the INT group's diaphragm atrophy improved in the fourth and fifth weeks (all P < .05). The BChE after the third week was higher (all P < .05). No significant differences in respiratory mechanical indices and clinical outcomes were found in the surviving patients between the groups.
INT improved the diaphragm atrophy and muscle mass of critically ill patients receiving prolonged MV. There was no evidence that increasing protein to the target amount of 2.0 g/kg/d is related to improvement in clinical prognosis for patients receiving prolonged MV.
我们的目的是评估高蛋白(目标为2.0 g/kg/d)对接受长时间机械通气(MV)患者膈肌萎缩及临床预后的影响。
这项前瞻性、随机、对照、单中心研究纳入了41例接受MV≥7天的患者。患者被随机分为标准营养治疗(SNT)组和强化营养治疗(INT)组,随后每周评估计算机断层扫描分析的膈肌体积、作为肌肉量指标的丁酰胆碱酯酶(BChE)水平以及呼吸力学指标,以观察和比较两组之间的差异。
INT组的实际蛋白质摄入量(1.70±0.21 vs 1.06±0.21 g/kg/d,P<.001)和热量摄入量(33.46±2.78 vs 25.75±4.81 kcal/kg/d,P<.001)与SNT组相比有显著差异。与SNT组相比,INT组的膈肌萎缩在第4周和第5周有所改善(均P<.05)。第3周后的BChE更高(均P<.05)。两组存活患者的呼吸力学指标和临床结局无显著差异。
INT改善了接受长时间MV的重症患者的膈肌萎缩和肌肉量。没有证据表明将蛋白质增加至目标量2.0 g/kg/d与接受长时间MV患者的临床预后改善有关。